Neonatal jaundice. Neonatal jaundice, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Orlistat (a product of Sanafi Co. LTD at a dose of 6 mg/kg once administered as an oral suspension) and phototherapy (visible light with a wavelength of 490-490 nm
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Days to 7 Days
Inclusion criteria
Inclusion criteria: Term neonatal Neonatal weight between 2500- 4000 grams 2-7 days old neonatal Total serum bilirubin level 13-25 mg/dl Direct bilirubin level less than 2 mg/dL or less than 15% from total serum bilirubin
Exclusion criteria
Exclusion criteria: Infants with sepsis disease meningitis congenital anomalies dehydration hemolytic disease Conjugate Hyperbilirubinemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total serum bilirubin. Timepoint: Before starting treatment and 12 and 24 hours after starting treatment. Method of measurement: Standard protocol (Using diazo solutions and photometric method).;Serum conjugated bilirubin. Timepoint: Before starting treatment and 12 and 24 hours after starting treatment. Method of measurement: Standard protocol (photometric method). | — |
Secondary
| Measure | Time frame |
|---|---|
| Length of hospitalization. Timepoint: End of study. Method of measurement: Based on hours. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMurtaza Habibi
Qazvin University of Medical Sciences
Outcome results
None listed